02718nam 22006251 450 991078893540332120230803033156.01-60805-775-5(CKB)3710000000057223(EBL)1531936(OCoLC)862612463(SSID)ssj0001158745(PQKBManifestationID)11683768(PQKBTitleCode)TC0001158745(PQKBWorkID)11106416(PQKB)11635386(MiAaPQ)EBC1531936(Au-PeEL)EBL1531936(CaPaEBR)ebr10795308(EXLCZ)99371000000005722320131114h20132013 uy 0engur|n|---|||||txtccrFrontiers in clinical drug researchVolume 2CNS and neurological disorders /editor, Atta-ur-RahmanSharjah, U.A.E. ;Oak Park, Illinois :Bentham Science Publishers,[2013]©20131 online resource (373 p.)Frontiers in clinical drug research ;volume 2Description based upon print version of record.1-60805-776-3 Includes bibliographical references and index.Cover; Title; EUL; Contents; Foreword; Preface; List of Contributors; Chapter 01; Chapter 02; Chapter 03; Chapter 04; Chapter 05; Chapter 06; Chapter 07; Chapter 08; IndexFrontiers in Clinical Drug Research - CNS and Neurological Disorders is an ebook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the ebook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended fFrontiers in Clinical Drug Research - CNS and Neurological DisordersCNS and neurological disordersBiopharmaceuticsDrugsDesignMedical innovationsPharmaceutical chemistryBiopharmaceutics.DrugsDesign.Medical innovations.Pharmaceutical chemistry.610.28Rahman Atta-ur-1942-544456MiAaPQMiAaPQMiAaPQBOOK9910788935403321Frontiers in clinical drug research3686114UNINA